Rebranding Gout: Could a Name Change for Gout Improve Adherence to Urate-Lowering Therapy?

导出 LinkOut

翻译打印收藏纠错

作者： Matthew J,Coleshill ^[1] ; Eindra,Aung ^[2] ; Jane E,Carland ^[3] ; Kate,Faasse ^[4] ; Sophie,Stocker ^[3] ; Richard O,Day ^[4]

作者单位： St Vincent's Clinical School, UNSW Medicine, UNSW Sydney, Sydney, Australia. m.coleshill@unsw.edu.au. ^[1] Department of Clinical Pharmacology, & Toxicology, Therapeutics Centre, St Vincent's Hospital, Sydney, Level 2 Xavier Building, Darlinghurst, NSW, 2010, Australia. m.coleshill@unsw.edu.au. ^[2] St Vincent's Clinical School, UNSW Medicine, UNSW Sydney, Sydney, Australia. ^[3] Department of Clinical Pharmacology, & Toxicology, Therapeutics Centre, St Vincent's Hospital, Sydney, Level 2 Xavier Building, Darlinghurst, NSW, 2010, Australia. ^[4] School of Psychology, UNSW Sydney, Sydney, NSW, Australia. ^[5]

关键词 Allopurinol Gout Name change Treatment adherence Urate crystal arthritis Urate-lowering therapy

主题词慢性病(Chronic Disease);痛风(Gout);抗痛风药(Gout Suppressants);人类(Humans);男(雄)性(Male);服药依从性(Medication Adherence);尿酸(Uric Acid)

DOI 10.1007/s43441-020-00198-0

PMID 32661926

发布时间 2021-06-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Therapeutic innovation & regulatory science

2021年55卷1期

138-141页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Rebranding Gout: Could a Name Change for Gout Improve Adherence to Urate-Lowering Therapy?

Therapeutic innovation & regulatory science

相似文献

Therapeutic innovation & regulatory science

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Rebranding Gout: Could a Name Change for Gout Improve Adherence to Urate-Lowering Therapy?

Therapeutic innovation & regulatory science

相似文献

Therapeutic innovation & regulatory science

相关期刊

检索历史清除